Literature DB >> 24154922

Surgical techniques for implanting implantable cardioverter defibrillators in children and infants.

Shoji Suzuki1, Shinya Motohashi, Masahiko Matsumoto.   

Abstract

Implantable cardioverter defibrillators (ICDs) are now being used in children. ICDs can be used to prevent sudden cardiac death caused by not only congenital heart defects, but also various non-structural diseases, such as long QT syndrome. However, a standard implantation technique for children, especially infants, has not yet been established. As the surgical implantation in infants is not amenable to transvenous lead placement, it was necessary to choose from epicardial, subcutaneous and pericardial ICD systems. However, many of these systems are associated with high rates of late complications. Lead fracture, insulation breakage, migration, buckling or crinkling of the patch lead and constrictive pericarditis have been reported as the most common lead-related complications. An increase in the defibrillation threshold is another issue that must be considered when using an ICD in a child or infant. Further studies on the outcomes, psychosomatic impact and other specific complications in the pediatric population need to be considered. The clinical use of ICDs in infants is still limited. Therefore, it is important to have many surgical options available so that the treatment can be custom-tailored to suit individual patients.

Entities:  

Mesh:

Year:  2013        PMID: 24154922     DOI: 10.1007/s00595-013-0755-6

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  46 in total

1.  Successful implantation of a cardioverter defibrillator in an infant.

Authors:  H Watanabe; J Hayashi; M Haga; M Saito; H Suzuki; S Sato
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

2.  ICD Implantation in infants and small children: the extracardiac technique.

Authors:  Thomas Kriebel; Wolfgang Ruschewski; Maria Gonzalez y Gonzalez; Katharina Walter; Johannes Kroll; Christoph Kampmann; Markus Heinemann; Heike Schneider; Thomas Paul
Journal:  Pacing Clin Electrophysiol       Date:  2006-12       Impact factor: 1.976

3.  Chronic rise in defibrillation threshold with a hybrid lead system.

Authors:  R V Tummala; D R Riggio; R W Peters; S R Shorofsky; M R Gold
Journal:  Am J Cardiol       Date:  1996-08-01       Impact factor: 2.778

4.  Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial.

Authors:  Niraj Varma; Andrew E Epstein; Anand Irimpen; Robert Schweikert; Charles Love
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

5.  Termination of malignant ventricular arrhythmias with an implanted automatic defibrillator in human beings.

Authors:  M Mirowski; P R Reid; M M Mower; L Watkins; V L Gott; J F Schauble; A Langer; M S Heilman; S A Kolenik; R E Fischell; M L Weisfeldt
Journal:  N Engl J Med       Date:  1980-08-07       Impact factor: 91.245

6.  Efficacy of an implantable cardioverter-defibrillator in a neonate with LQT3 associated arrhythmias.

Authors:  Arend D J Ten Harkel; Maarten Witsenburg; Peter L de Jong; Luc Jordaens; Marjolein Wijman; Arthur A M Wilde
Journal:  Europace       Date:  2005-01       Impact factor: 5.214

7.  Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Domenico Corrado; Loira Leoni; Mark S Link; Paolo Della Bella; Fiorenzo Gaita; Antonio Curnis; Jorge Uriarte Salerno; Diran Igidbashian; Antonio Raviele; Marcello Disertori; Gabriele Zanotto; Roberto Verlato; Giuseppe Vergara; Pietro Delise; Pietro Turrini; Cristina Basso; Franco Naccarella; Francesco Maddalena; N A Mark Estes; Gianfranco Buja; Gaetano Thiene
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

8.  Direct intracardiac placement of an automatic implantable cardioverter defibrillator coil lead in a small child.

Authors:  Michal J Kantoch; Ivan M Rebeyka; Lois A Houlden; John D Dyck
Journal:  Europace       Date:  2007-04-27       Impact factor: 5.214

9.  Initial experience with implantable cardioverter defibrillator systems using epicardial and pleural electrodes in pediatric patients.

Authors:  Urs Bauersfeld; Maren Tomaske; Ali Dodge-Khatami; Mariette Rahn; Christian J Kellenberger; René Prêtre
Journal:  Ann Thorac Surg       Date:  2007-07       Impact factor: 4.330

10.  Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics.

Authors:  Mark E Alexander; Frank Cecchin; Edward P Walsh; John K Triedman; Laura M Bevilacqua; Charles I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2004-01
View more
  3 in total

1.  Resuscitated Sudden Cardiac Arrest of a Neonate with Congenital LQT Syndrome-Associated Torsades de Pointes: A Case Report and Literature Review.

Authors:  Yen-Teng Hsu; Pi-Chang Lee; Yu-Hsuan Chen; Shu-Jen Yeh; Ming-Ren Chen; Kung-Hong Hsu; Chung-I Chang; Wei-Ting Lai; Wei-Li Hung
Journal:  J Cardiovasc Dev Dis       Date:  2022-06-09

2.  Epicardially placed implantable cardioverter-defibrillator for a child with congenital long QT syndrome.

Authors:  Hirotaro Sugiyama; Motomi Tachibana; Hiroshi Morita; Nobuhiro Nishii; Akihito Miyoshi; Hiroyasu Sugiyama; Koji Nakagawa; Atsuyuki Watanabe; Kazufumi Nakamura; Hiroshi Ito
Journal:  J Arrhythm       Date:  2016-11-10

3.  European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections-endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm Society (LAHRS), International Society for Cardiovascular Infectious Diseases (ISCVID) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Carina Blomström-Lundqvist; Vassil Traykov; Paola Anna Erba; Haran Burri; Jens Cosedis Nielsen; Maria Grazia Bongiorni; Jeanne Poole; Giuseppe Boriani; Roberto Costa; Jean-Claude Deharo; Laurence M Epstein; Laszlo Saghy; Ulrika Snygg-Martin; Christoph Starck; Carlo Tascini; Neil Strathmore
Journal:  Europace       Date:  2020-04-01       Impact factor: 5.214

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.